| Outcome Measures: |
Primary: HbA1c, Change from Visit 1(Baseline Visit) in HbA1c at Visit 5(week 16) | Secondary: FPG(Fasting Plasma Glucose), Change from Visit 1(Baseline Visit) in FPG at Visit 5(week 16)|Weight, Change from Visit 1(Baseline Visit) in weight at Visit 5(week 16)|BMI, Change from Visit 1(Baseline Visit) in BMI at Visit 5(week 16)|HbA1c <7.0%, The proportion of patients who achieve an HbA1c<7.0% at Visit 5(week 16)|HbA1c <6.5%, The proportion of patients who achieve an HbA1c<6.5% at Visit 5(week 16)|Total Cholesterol, Change from Visit 1(Baseline Visit) in Total Cholesterol at Visit 5(week 16)|LDL Cholesterol, Change from Visit 1(Baseline Visit) in LDL Cholesterol at Visit 5(week 16)|HDL Cholesterol, Change from Visit 1(Baseline Visit) in HDL Cholesterol at Visit 5(week 16)|Triglyceride, Change from Visit 1(Baseline Visit) in Triglyceride at Visit 5(week 16)|C-peptide, Change from Visit 1(Baseline Visit) in C-peptide at Visit 5(week 16)|Insulin, Change from Visit 1(Baseline Visit) in insulin at Visit 5(week 16)|hsCRP, Change from Visit 1(Baseline Visit) in hsCRP at Visit 5(week 16)|HOMA-β, Change from Visit 1(Baseline Visit) in HOMA-β at Visit 5(week 16)|HOMA-IR, Change from Visit 1(Baseline Visit) in HOMA-IR at Visit 5(week 16)
|
